Table of Contents
Amylin Pharmaceuticals, Inc.
Agenda
Amylin Pharmaceuticals, Inc.
Safe Harbor Statement
Current Pipeline Status
Amylin Goals for 2001 SYMLIN™ (pramlintide acetate)
Amylin Goals for 2001 AC2993 and AC2993 LAR
Amylin Goals for 2001 AC3056 and Research
SYMLIN™ (pramlintide acetate) Overview
SYMLIN Patient Focus People With Diabetes Who Use Insulin
SYMLIN Market Opportunity United States
SYMLIN Market Opportunity: US Insulin Prescriptions Highly Concentrated
SYMLIN Commercial Operations Sales Planning Model
SYMLIN Commercial Operations Experienced Core Commercial Team
Amylin the Hormone Campaign
Amylin the Hormone Campaign
Upcoming Medical Meetings
AC2993 (synthetic exendin-4) Overview
AC2993 (synthetic exendin-4) Patient Focus
AC2993 (synthetic exendin-4) Potential Markets
AC2993 (synthetic exendin-4)
AC2993 (synthetic exendin-4)
AC2993 LAR
AC3056
Expanding the Pipeline
Financial Overview
2001 Corporate Presentations
Goals for 2001
|